Nordea Investment Management Ab Coherus Bio Sciences, Inc. Transaction History

Nordea Investment Management Ab

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$5.86 - $13.23 $151,475 - $341,982	25,849 Added 7.14%	388,047 $2.78 Million
Q1 2022 Apr 11, 2022	BUY	$10.92 - $16.41 $113,775 - $170,975	10,419 Added 2.96%	362,198 $4.78 Million
Q4 2021 Jan 20, 2022	BUY	$15.81 - $18.99 $23,272 - $27,953	1,472 Added 0.42%	351,779 $5.9 Million
Q3 2021 Nov 01, 2021	SELL	$12.68 - $17.79 $4.44 Million - $6.23 Million	-350,307 Reduced 50.0%	350,307 $5.75 Million
Q3 2021 Nov 01, 2021	BUY	$12.68 - $17.79 $4.35 Million - $6.11 Million	343,312 Added 96.08%	700,614 $11.3 Million
Q2 2021 Jul 16, 2021	BUY	$12.95 - $15.41 $743,135 - $884,302	57,385 Added 19.13%	357,302 $4.94 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $94,133 - $139,633	-6,528 Reduced 2.13%	299,917 $4.34 Million
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $415,622 - $475,356	25,098 Added 8.92%	306,445 $5.33 Million
Q3 2020 Nov 09, 2020	SELL	$17.41 - $19.89 $4.8 Million - $5.48 Million	-275,605 Reduced 49.48%	281,347 $5.19 Million
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $4 Million - $5.32 Million	277,514 Added 99.31%	556,952 $9.95 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $112,277 - $216,761	9,621 Added 3.57%	279,438 $4.68 Million
Q4 2019 Feb 11, 2020	BUY	$16.33 - $21.37 $4.41 Million - $5.77 Million	269,817 New	269,817 $4.82 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.